Form D · Pharmaceuticals

AFFINIMARK TECHNOLOGIES INC

New Haven, CT · CIK 0001429101

Offering snapshot reported Mar 3, 2016 · SEC filing

Reported sold: $1.55M
Investors reported: 1
Minimum accepted: $0
First sale: Feb 12, 2016

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Mar 3, 2016	Initial	$1,550,000	No comparison	1	SEC filing
Mar 3, 2016	Amendment	$1,550,000	$0vs Mar 3, 2016	1	SEC filing
Oct 8, 2010	Initial	$821,894	No comparison	8	SEC filing
Mar 3, 2008	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Debt, Option to acquire, Security to be acquired
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-258481

Source: Form D, filed Mar 3, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Kevin Crowley	Director
Larry Dillaha	Executive
Konstantine Drakonakis	Director
Patrick Fourteau	Executive
Michael Milligan	Executive
Harry H Penner Jr	Director, Executive
Harry H. Penner, Jr.	Director, Executive
Vincent Pieribone	Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

300 George Street Suite 561
New Haven, CT, 06511